Atlas Trials

Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma

Clinical trial NCT07454031 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07454031
Sponsor
Peking University
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Peritoneal (Metastatic) Cancer
Start date
2026-03-15
Primary completion
2026-12-31
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.